You participated in our first townhall of 2025 in Q1, at which we got together as ONE Team. On 13 March we get a better overview on all functions, platforms and expert groups among peers in a new format to drive DSO initiatives and digital transformation. POAP dropped for Bayer DT&IT Pharma Design by stefankai with Canva POAP Terms & Conditions: https://bayer.com/poap Bayer IT POAP Collection: https://collections.poap.xyz/bayer-it/

You were invited to our Q4/2024 Townhall, where we explored our future organization based on what has been agreed upon until then. Updates from our Leadership Team included insights from the PH Strategy Summit, which did initiate discussions on our financials and the strategic mid- and long-term outcomes for Pharma. Additionally, we reflected on the results of the Ownership Pulse (formerly known as Employee Voice), discussed further considerations, and allocated time for a Q&A session. This token serves as appreciation for and proof of your participation. POAP dropped for Bayer DT&IT Pharma Design by stefankai with Canva POAP Terms & Conditions: https://bayer.com/poap Bayer IT POAP Collection: https://collections.poap.xyz/bayer-it/

Thank you for attending today's DT & IT Pharma Townhall! In today's meeting, we delved deeper into the successful launch of the Pharma Control Tower (go/PHCT), which serves as a central entry point for all your needs related to financial, operational stability, and governance for your applications, portfolios, and functions. Additionally, we shared some updates on the rollout of MyGenAssist at Pharma, highlighting our crucial role as key ambassadors. This past year has underscored the accelerated pace of innovation, with GenAI standing out as a prime example of the agility needed to proactively evolve our skill sets. Furthermore, we collectively reviewed our key priorities for 2024 and provided updates on our DSO learning journey. In summary: ///// PH Control Tower ///// Business priorities per department ///// MyGenAssist roll-out PH ///// DSO Champions update Bayer terms & conditions apply: https://www.bayer.com/en/poap-tc

Another DSO Open MIC session is in the books! Whether you have attended the morning or afternoon session, without a doubt you have contributed significantly to the success of today's event. These sessions are a space for open exchanges about ongoing topics around DSO and an opportunity to share, ask questions, provide feedback, or just listen. Everyone is invited to attend, participation is voluntary, and the sessions will not be recorded. Bayer terms & conditions apply: https://www.bayer.com/en/poap-tc

Linus Pauling (28.Feb.1901-1994) was an influential American chemist, biochemist, and peace activist, renowned for his groundbreaking work in quantum chemistry and molecular biology. He is one of few individuals to have received 2 Nobel Prizes in different fields, and the only one to receive 2 unshared Nobel prizes: Chemistry (1954, nature of the chemical bond and its application to the elucidation of the structure of complex substances) and Peace (1962, efforts against nuclear weapons testing). Pauling's scientific contributions include the concept of electronegativity, the nature of the chemical bond, and the alpha helix structure of proteins. He was a prolific writer, 1,200+ papers and books, including "The Nature of the Chemical Bond", one of the most influential chemistry books ever published. Racy: Theoretical physicist Robert Oppenheimer attempted a rendezvous with Pauling's wife in Mexico. She refused and it ruined their friendship. Pauling was a controversial figure, partly due to his unsupported claim that high doses of Vitamin C are a cure for the common cold and cancer. This is called "Nobel disease" or "Nobelitis", the phenomena when some Nobel Prize laureates, often in their later years, adopt unconventional or scientifically questionable beliefs. He was a critic of the Vietnam War and advocate for nuclear disarmament, giving him a rare blend of brilliance in both science and social activism. https://bit.ly/3Ih9XVs Art&Text🫶ChatGPT.

Rare diseases are defined by their low prevalence in the population, leading to challenges in diagnosis, research, and treatment. Definitions vary; in the US, a disease is rare if it affects fewer than 1:1,500 individuals, Europe 1:2,000, Japan 1:2,500. There are some 7,000 rare diseases, impacting around 6-8% of the world at some point, some 300 million currently. They are incredibly diverse, ranging from genetic disorders to rare cancers, and can be chronic, progressive, debilitating, and often life-threatening. Some well-known rare diseases include cystic fibrosis, Duchenne muscular dystrophy, and Huntington's disease, each with their own unique symptoms, treatment challenges, and research needs. Rare diseases are closely related to orphan diseases, a term that originally referred to diseases neglected by drug developers due to the small market potential. However, the terms are now often used interchangeably. Legislation such as the Orphan Drug Act of 1983 in the U.S. has incentivized pharmaceutical companies to develop treatments for rare (orphan) diseases, offering benefits like tax credits and exclusive marketing rights. The rarity and diversity of these diseases pose significant hurdles for research and clinical trials, Raising awareness and support for those affected are crucial for research funding to develop diagnostics, treatments, and hopefully cures. https://en.wikipedia.org/wiki/Rare_disease Art+Text supported by ChatGPT

World Obesity Day, observed on March 4th, is dedicated to promoting practical solutions to end the global obesity crisis. Obesity, a complex health condition characterized by excessive body fat, is a major risk factor for various diseases, including diabetes, cardiovascular diseases, and certain cancers. Historically, obesity was mostly seen as a symbol of wealth and prosperity. Many of the Venus figurines, made 20,000+ years ago, are corpulent ladies and thought to symbolize fertility, health, and abundance, maybe idealizing body size in times where food scarcity was a constant threat. Ancient medical texts saw it as a health risk, but only in the 20th century research highlighted it as a medical condition. It's caused by a combination of genetic, behavioral, and environmental factors. Poor diet, lack of physical activity, and sedentary lifestyles are key contributors. Obesity affects all age groups and socioeconomic classes, over 10% of the population. However, prevalence rates vary significantly across different regions and populations. In recent years, developing countries have witnessed a rapid rise in obesity rates, a shift attributed to urbanization and changes in lifestyle and dietary habits. Obesity's toll on health, life quality, and economy is huge. World Obesity Day calls for united efforts for change, advocating for healthy lifestyles, supportive policies, and research to combat this challenge. https://en.wikipedia.org/wiki/Obesity Art&Text🫶ChatGPT.